An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors
Completed · Phase 1
Conditions studied: Advanced Solid Tumors
In brief
This is an extension study of ABT-806 for subjects with advanced solid tumors.
Key facts
- Study ID
- NCT01406119
- Run by
- AbbVie (prior sponsor, Abbott)
- People needed
- 14
- Starts
- 2011-10-01
- Expected to finish
- 2017-01-01
- Last updated by the study team
- 2017-01-27
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject has completed a prior study utilizing ABT-806 or 111ln ABT-806 (ABT 806i) and the Investigator believes that continued treatment with ABT-806 is in the best interest of the subject.
- Women of childbearing potential and men must agree to use adequate contraception (one of the following listed below) prior to study entry, for the duration of study participation and for a period of 3 months. Female subjects considered not of childbearing potential must be documented as being surgically sterile or post-menopausal for at least 1 year.
- Subject is capable of understanding and complying with parameters as outlined in the protocol and the subject or the subject's legal acceptable representative is able to sign informed consent, approved by an Institutional Review Board (IRB) prior to the initiation of any or study-specific procedures.
You may not qualify if…
- Subject discontinued ABT-806 or111ln ABT-806 (ABT-806i) administration before completing the prior study (due to disease progression, toxicity, withdrawn consent, other).
- Subject has any medical condition which in the opinion of the investigator places the subject at an unacceptably high risk for toxicities.
- Subject is a lactating or pregnant female.
Where it is running
- Site Reference ID/Investigator# 58883 — Baltimore, Maryland, United States
- Site Reference ID/Investigator# 58882 — Boston, Massachusetts, United States
- Site Reference ID/Investigator# 60619 — Heidelberg, Australia
- Site Reference ID/Investigator# 63845 — Herston, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.